건강보험 청구자료를 이용한 우리나라 뇌졸중 환자의 사회경제적 비용 추계
Socioeconomic Costs of Stroke in Korea: Estimated from the Korea National Health Insurance Claims Database
2
조회
0
다운로드
26
인용
0
참고문헌
키워드
초록
Objectives : To estimate the annual socioeconomic costs of stroke in Korea in 2005 from a societal perspective. Methods : We identified those 20 years or older who had at least one national health insurance (NHI) claims record with a primary or a secondary diagnosis of stroke (ICD-10 codes: I60-I69, G45) in 2005. Direct medical costs of the stroke were measured from the NHI claims records. Direct non-medical costs were estimated as transportation costs incurred when visiting the hospitals. Indirect costs were defined as patients and caregivers productivity loss associated with office visits or hospitalization. Also, the costs of productivity loss due to premature death from stroke were calculated. Results : A total of 882,143 stroke patients were identified with prevalence for treatment of stroke at 2.44%. The total cost for the treatment of stroke in the nation was estimated to be 3,737 billion Korean won (KRW) which included direct costs at 1,130 billion KRW and indirect costs at 2,606 billion KRW. The per-capita cost of stroke was 3 million KRW for men and 2 million KRW for women. The total national spending for hemorrhagic and ischemic stroke was 1,323 billion KRW and 1,553 billion KRW, respectively, which together consisted of 77.0% of the total cost for stroke. Costs per patient for hemorrhagic and ischemic stroke were estimated at 6 million KRW and 2 million KRW, respectively. Conclusions : Stroke is a leading public health problem in Korea in terms of the economic burden. The indirect costs were identified as the largest component of the overall cost.
Abstract
Objectives : To estimate the annual socioeconomic costs of stroke in Korea in 2005 from a societal perspective. Methods : We identified those 20 years or older who had at least one national health insurance (NHI) claims record with a primary or a secondary diagnosis of stroke (ICD-10 codes: I60-I69, G45) in 2005. Direct medical costs of the stroke were measured from the NHI claims records. Direct non-medical costs were estimated as transportation costs incurred when visiting the hospitals. Indirect costs were defined as patients and caregivers productivity loss associated with office visits or hospitalization. Also, the costs of productivity loss due to premature death from stroke were calculated. Results : A total of 882,143 stroke patients were identified with prevalence for treatment of stroke at 2.44%. The total cost for the treatment of stroke in the nation was estimated to be 3,737 billion Korean won (KRW) which included direct costs at 1,130 billion KRW and indirect costs at 2,606 billion KRW. The per-capita cost of stroke was 3 million KRW for men and 2 million KRW for women. The total national spending for hemorrhagic and ischemic stroke was 1,323 billion KRW and 1,553 billion KRW, respectively, which together consisted of 77.0% of the total cost for stroke. Costs per patient for hemorrhagic and ischemic stroke were estimated at 6 million KRW and 2 million KRW, respectively. Conclusions : Stroke is a leading public health problem in Korea in terms of the economic burden. The indirect costs were identified as the largest component of the overall cost.
참고문헌 (40)
- Report on Death Causes 2005, "Korea National Statistical Office", ~ (2006)
- Luengo-Fernandez R, "The cost of cardiovascular diseases in the United Kingdom", Heart, 92(10), pp.1384~1389 (2006)
- Leal J, "Economic burden of cardiovascular diseases in the enlarged European Union", Eur Heart J, 27(13), pp.1610~1619 (2006)
- Paul SL, "The large and growing burden of stroke", Curr Drug Targets, 8(7), pp.786~793 (2007)
- World Health Report 2004, "World Health Organization", ~ (2004)
- Report on the Social Statistics Survey 2005, "Korea National Statistical Office", ~ (2006)
- Council of the European Union, "2586th Council Meeting-Employment, Social Policy, Health and Consumer Affairs" (2004)
- 김선하,, "체질량지수와 출혈성 뇌졸중 발생간의 관련성에 대한 환자-대조군연구", 예방의학회지, 40(4), pp.313~320 (2007), 대한예방의학회
- Matchar DB, "Costeffectiveness of antiplatelet agents in secondary stroke prevention: The limits of certainty", Value Health, 8(5), pp.572~580 (2005)
- Matchar DB, "Cost of stroke", Stroke Clin Updates, 5(3), pp.9~12 (1994)
- Taylor TN, "Lifetime cost of stroke in the United States", Stroke, 27(9), pp.1459~1466 (1996)
- Terent A, "Costs of stroke in Sweden: A national perspective", Stroke, 25(12), pp.2363~2369 (1994)
- Persson U, "Direct costs of stroke for a Swedish population", Int J Technol Assess Health Care, 6(1), pp.125~137 (1990)
- Chan B, "Cost of stroke in Ontario,1994-1995", CMAJ, 159(6), pp.S2~S7 (1998)
- Evers SM, "Cost of stroke in The Netherlands from a societal perspective", Stroke, 28(7), pp.1375~1381 (1997)
- Bergman L, "Costs of medical care after firstever stroke in The Netherlands", Stroke, 26(10), pp.1830~1836 (1995)
- Isard PA, "The cost of stroke to the national health service in Scotland", Cerebrovasc Dis, 2(1), pp.47~50 (1992)
- Scott WG, "Ischaemic stroke in New Zealand: An economic study", N Z Med J, 107(989), pp.443~446 (1994)
- Rossnagel K, "Medical resource use and costs of health care after acute stroke in Germany", Eur J Neurol, 12(11), pp.862~868 (2005)
- Dodel RC, "Resource utilization and costs of stroke unit care in Germany", Value Health, 7(2), pp.144~152 (2004)
- Yoneda Y, "Hospital cost of ischemic stroke and intracerebral hemorrhage in Japanese stroke centers", Health Policy, 73(2), pp.202~211 (2005)
- Rice D, "Cost-of-illness studies: Fact or fiction", Lancet, 344(8936), pp.1519~1520 (1994)
- 정우진, "음주의 사회경제적 비용 추계", 예방의학회지, 39(1), pp.21~29 (2006), 대한예방의학회
- Kang HY, "Economic burden of smoking in Korea", Tob Control, 12(1), pp.37~44 (2003)
- 박춘선, "건강보험 청구자료를 이용한 우리나라 천식환자의 질병비용부담 추계", 예방의학회지, 39(5), pp.397~403 (2006), 대한예방의학회
- Sung Man Chang, "Economic Burden of Schizophrenia in South Korea", Journal of Korean Medical Science, 23(2), pp.167~175 (2008), 대한의학회
- 정영호, "5대 사망원인 질병의 사회, 경제적 비용추계", 재정논집, 18(2), pp.77~104 (2004), 한국재정학회
- National Health Insurance Corporation, "2005 Survey on National Health Insurance Patients Out-of-pocket Expenditure" (2006)
- Korea National Statistical Office, "Yearbook of Labor Statistics 2005" (2006)
- Korea Ministry of Labor, "Statistics for Wage Structure 2005" (2006)
- "Life time table"[URL]
- Drummond M, "Methods for the Economic Evaluation of Health Care Program" (1997), Oxford University Press
- Korea National Statistical Office, "Age-andgender-specific Population Size 2005" (2006)
- Organization for Economic Co-operation and Development, "OECD Health Data 2008: Statistics and Indicators for 30 Countries" (2008)
- Barrett-Connor E, "The economic and human costs of osteoporotic fracture", Am J Med, 98(2A), pp.3S~8S (1995)
- Kang S, "Current epidemiological status of cerebrovascular disease", J Korean Neurosurg Soc, 28(4), pp.509~513 (1999)
- Feigin VL, "Stroke epidemiology in Novosibirsk, Russia: A population-based study", Mayo Clin Proc, 70(9), pp.847~852 (1995)
- Hodgson TA, "Medical care expenditures for hypertension, its complications, and its comorbidities", Med Care, 39(6), pp.599~615 (2001)
- Arredondo A, "Epidemiologic changes and economic burden of hypertension in Latin America: Evidence from Mexico", Am J Hypertens, 19(6), pp.553~559 (2006)
- 이건세, "뇌졸중 환자의 의료 자원 이용과 비용 지출: 환자의 관점에서", 대한신경과학회지, 22(6), pp.583~589 (2004), 대한신경과학회